Penghui Yang

Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

Features, Evaluation and Treatment Coronavirus (COVID-19)

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice

Mechanisms of SARS-CoV-2 entry into cells

The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Nervous system involvement after infection with COVID-19 and other coronaviruses

Artificial Intelligence (AI) applications for COVID-19 pandemic

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Are children less susceptible to COVID-19?

Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19

Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma

Industry 4.0 technologies and their applications in fighting COVID-19 pandemic

Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers

Internet of things (IoT) applications to fight against COVID-19 pandemic

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

COVID-19: consider cytokine storm syndromes and immunosuppression

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein

A longitudinal study on the mental health of general population during the COVID-19 epidemic in China

Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults

Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

The Tumor Microenvironment Innately Modulates Cancer Progression

Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults

Respiratory Epithelial Cells Respond to Lactobacillus plantarum but Provide No Cross-Protection against Virus-Induced Inflammation

Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation

Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus

Corticosteroid Treatment Ameliorates Acute Lung Injury Induced by 2009 Swine Origin Influenza A (H1N1) Virus in Mice

Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice

C-C Motif Chemokine Ligand 2 (CCL2) Mediates Acute Lung Injury Induced by Lethal Influenza H7N9 Virus

Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge